Sort by

Send to

Choose Destination

Links from PubMed

Items: 16


Frequent Episodes of Detectable Viremia in HIV Treatment-Experienced Children is Associated with a Decline in CD4+ T-cells Over Time.

Paintsil E, Martin R, Goldenthal A, Bhandari S, Andiman W, Ghebremichael M.

J AIDS Clin Res. 2016 Apr;7(4). pii: 565.


Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China.

Zheng J, Zhao D.

BMC Res Notes. 2014 Jul 3;7:419. doi: 10.1186/1756-0500-7-419.


Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.

Vardhanabhuti S, Taiwo B, Kuritzkes DR, Eron JJ Jr, Bosch RJ.

Antivir Ther. 2015;20(1):73-6. doi: 10.3851/IMP2772.


HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure.

Swenson LC, Min JE, Woods CK, Cai E, Li JZ, Montaner JS, Harrigan PR, Gonzalez-Serna A.

AIDS. 2014 May 15;28(8):1125-34. doi: 10.1097/QAD.0000000000000203.


Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization.

Zych C, Domling A, Ayyavoo V.

Drug Des Devel Ther. 2013;7:403-12. doi: 10.2147/DDDT.S44139.


Long-term efficacy of first line antiretroviral therapy in Indian HIV-1 infected patients: a longitudinal cohort study.

Neogi U, Heylen E, Shet A, Chandy S, Shamsunder R, Sönnerborg A, Ekstrand ML.

PLoS One. 2013;8(1):e55421. doi: 10.1371/journal.pone.0055421.


Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.

Taiwo B, Gallien S, Aga E, Ribaudo H, Haubrich R, Kuritzkes DR, Eron JJ Jr.

J Infect Dis. 2011 Aug 15;204(4):515-20. doi: 10.1093/infdis/jir353.


Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.

El-Khatib Z, Ekstrom AM, Ledwaba J, Mohapi L, Laher F, Karstaedt A, Charalambous S, Petzold M, Katzenstein D, Morris L.

AIDS. 2010 Jul 17;24(11):1679-87. doi: 10.1097/QAD.0b013e32833a097b.


Impact of remote versus local sampling on sensitivity of genotypic antiretroviral resistance testing.

Balestrieri M, Marconi A, Meini G, Rosi A, Saladini F, Vicenti I, Razzolini F, Zazzi M.

J Clin Microbiol. 2010 Jun;48(6):2321-2. doi: 10.1128/JCM.02394-09. No abstract available.


Oral complications of HIV disease.

Leao JC, Ribeiro CM, Carvalho AA, Frezzini C, Porter S.

Clinics (Sao Paulo). 2009 May;64(5):459-70. Review.


Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria.

Meya D, Spacek LA, Tibenderana H, John L, Namugga I, Magero S, Dewar R, Quinn TC, Colebunders R, Kambugu A, Reynolds SJ.

J Int AIDS Soc. 2009 Mar 4;12:3. doi: 10.1186/1758-2652-12-3.


Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failure.

Goetz MB, Ferguson MR, Han X, McMillan G, St Clair M, Pappa KA, McClernon DR, O'Brien WA.

J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):541-9.


Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.

Tobin NH, Learn GH, Holte SE, Wang Y, Melvin AJ, McKernan JL, Pawluk DM, Mohan KM, Lewis PF, Mullins JI, Frenkel LM.

J Virol. 2005 Aug;79(15):9625-34.


Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.

Kantor R, Shafer RW, Follansbee S, Taylor J, Shilane D, Hurley L, Nguyen DP, Katzenstein D, Fessel WJ.

AIDS. 2004 Jul 23;18(11):1503-11.

Items per page

Supplemental Content

Support Center